MayBio Biomedical

Beijing, China · Founded 2019 · Privately Held (backing)

Developer of surgical implant products containing human extracellular matrix and collagen designed for medical beauty. MayBio Biomedical is based in Beijing, China and was founded in 2019. Its last reported valuation was $11.4 million in Aug 2020. It has raised $2.9 million.

Last reported valuation

$11.4M

Oct 2026

Priced at

—

Total raised

$2.9M

Last round

—

How much has MayBio Biomedical raised?

$2.9Macross 0 recorded rounds

Free account

More of MayBio Biomedical with a free account

·Watch MayBio Biomedical: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

MayBio Biomedical investors

8 investors are on record for MayBio Biomedical, including Hunan Chasing Fund, Alwin Capital, Century Golden Resources Group and Beijing New Aerotropolis Fund Management.

For fundraisers

Raising for a company like MayBio Biomedical?

8 investors have backed MayBio Biomedical.

See all 8 investors →

Frequently asked about MayBio Biomedical

How much has MayBio Biomedical raised?: MayBio Biomedical has raised $2.9M in total across 0 recorded funding rounds.